Pharmaceutical Name
Erysipelothrix rhusiopathiae Bacterin 

• The first Erysipelas vaccine USDA licensed to provide protection against both mortality and disease caused by Erysipelas in swine

• Contains the exclusive safe and smooth Emunade^® adjuvant

• Delivers protection against Erysipelothrix rhusiopathiae infection through the growing period

 
Indications
Recommended for use in healthy swine at 3-4 weeks of age or older as an aid in the prevention of disease and mortality associated with Erysipelothrix rhusiopathiae in swine.

WARNING: Extreme caution should be used when injecting oil emulsion vaccines to avoid injecting your own finger or hand. Accidental injection can cause serious local reaction. Contact a physician immediately if accidental injection occurs. 
 
Dosage
For further information including dose rate and complete directions and warnings, please see the Product Label by clicking here.
 
RHUSIGEN is a trademark of Schering-Plough Animal Health Corporation.